Related Experiment Videos
Intrapartum fetal asphyxia: definition, diagnosis, and classification
1Department of Obstetrics and Gynecology, Queen's University, Kingston, Ontario, Canada.
American Journal of Obstetrics and Gynecology
|May 1, 1997
Summary
Fetal asphyxia, indicated by metabolic acidosis at birth, occurs in 2% of pregnancies. A new classification system uses newborn encephalopathy and organ complications to define severity, aiding clinical assessment.
Area of Science:
- Perinatal Medicine
- Neonatology
- Obstetrics
Background:
- Fetal asphyxia is a significant complication occurring in approximately 2% of deliveries.
- Diagnosing fetal asphyxia relies on evidence of metabolic acidosis, specifically an umbilical artery base deficit greater than 12 mmol/L.
- Current methods for classifying the severity of fetal asphyxia are limited due to unknown exposure duration and fetal response.
Purpose of the Study:
- To propose a novel classification system for the severity of fetal asphyxial exposure.
- To confirm asphyxial exposure using blood gas and acid-base assessments.
- To define severity based on newborn encephalopathy and organ system complications.
Main Methods:
- Confirmation of asphyxial exposure through blood gas and acid-base assessment.
- Identification of significant metabolic acidosis (umbilical artery base deficit > 12 mmol/L).
- Classification of severity based on the presence and extent of newborn encephalopathy and other organ system complications.
Main Results:
- A classification system is proposed that confirms asphyxial exposure via metabolic acidosis.
- Severity is categorized by the development of newborn encephalopathy and organ system dysfunction.
- The classification aims to standardize the assessment of fetal asphyxia severity.
Conclusions:
- The proposed classification provides a framework for assessing fetal asphyxia severity.
- Newborn encephalopathy and organ complications are key indicators for severity grading.
- Further research is needed to refine and validate this classification system for clinical use.